Depressive Disorder, Treatment-Resistant  >>  olanzapine/fluoxetine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
olanzapine/fluoxetine / Generic mfg.
NCT00958568: A Study in Relapse Prevention of Treatment-Resistant Depression

Completed
3
892
US, RoW
Olanzapine and Fluoxetine combination (OFC), Symbyax, LY900000, Fluoxetine, Prozac, LY1101440
Eli Lilly and Company
Treatment Resistant Depression
03/12
03/12

Download Options